STOCK TITAN

[Form 4] NuSkin Enterprises, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Daniel W. Campbell, a director of Nu Skin Enterprises (NUS), reported open-market sales of Class A common stock on 08/29/2025. The filing shows two disposal transactions: 9,046 shares sold at a weighted-average price of $12.12 and 23,391 shares sold at a weighted-average price of $12.10, for total reported disposals of 32,437 shares. After the transactions the report shows 39,216 shares held directly and 53,375 shares held indirectly, including shares held by an irrevocable family trust and by a limited liability company controlled by the reporting person and his spouse.

Daniel W. Campbell, amministratore di Nu Skin Enterprises (NUS), ha dichiarato vendite sul mercato aperto di azioni ordinarie di Classe A il 29/08/2025. Il documento riporta due operazioni di cessione: 9.046 azioni vendute a un prezzo medio ponderato di $12,12 e 23.391 azioni vendute a un prezzo medio ponderato di $12,10, per un totale di 32.437 azioni cedute. Dopo le operazioni il rapporto indica 39.216 azioni detenute direttamente e 53.375 azioni detenute indirettamente, incluse azioni in un trust familiare irrevocabile e in una società a responsabilità limitata controllata dalla persona segnalante e dalla sua coniuge.

Daniel W. Campbell, director de Nu Skin Enterprises (NUS), declaró ventas en mercado abierto de acciones ordinarias Clase A el 29/08/2025. La presentación muestra dos transacciones de disposición: 9.046 acciones vendidas a un precio promedio ponderado de $12,12 y 23.391 acciones vendidas a un precio promedio ponderado de $12,10, para un total de 32.437 acciones enajenadas. Tras las operaciones el informe muestra 39.216 acciones en posesión directa y 53.375 acciones en posesión indirecta, incluidas acciones mantenidas en un fideicomiso familiar irrevocable y en una sociedad de responsabilidad limitada controlada por la persona informante y su cónyuge.

Daniel W. Campbell은 Nu Skin Enterprises (NUS)의 이사로서 2025-08-29에 클래스 A 보통주에 대한 공개 시장 매도를 보고했습니다. 제출 문서에는 두 건의 처분 거래가 표시되어 있으며, 가중평균 가격 $12.12에 9,046주를 매도하고 가중평균 가격 $12.10에 23,391주를 매도하여 총 32,437주를 처분한 것으로 나옵니다. 거래 후 보고서에는 직접 보유 주식 39,216주와 간접 보유 주식 53,375주가 기재되어 있으며, 여기에는 취소 불가능한 가족 신탁과 보고자 및 배우자가 통제하는 유한책임회사(LLC)가 보유한 주식이 포함됩니다.

Daniel W. Campbell, administrateur de Nu Skin Enterprises (NUS), a déclaré des ventes sur le marché ouvert d'actions ordinaires de classe A le 29/08/2025. le dossier indique deux opérations de cession : 9 046 actions vendues à un prix moyen pondéré de 12,12 $ et 23 391 actions vendues à un prix moyen pondéré de 12,10 $, pour un total de 32 437 actions cédées. Après ces opérations, le rapport fait état de 39 216 actions détenues directement et de 53 375 actions détenues indirectement, y compris des actions détenues par un trust familial irrévocable et par une société à responsabilité limitée contrôlée par la personne déclarante et son conjoint.

Daniel W. Campbell, Direktor von Nu Skin Enterprises (NUS), meldete am 29.08.2025 Offenmarktverkäufe von Class-A-Stammaktien. Die Einreichung weist zwei Veräußerungstransaktionen aus: 9.046 Aktien verkauft zu einem gewichteten Durchschnittspreis von $12,12 und 23.391 Aktien verkauft zu einem gewichteten Durchschnittspreis von $12,10, insgesamt also 32.437 veräußerte Aktien. Nach den Transaktionen zeigt der Bericht 39.216 direkt gehaltene Aktien und 53.375 indirekt gehaltene Aktien, einschließlich Aktien, die in einem unwiderruflichen Familientrust und in einer von der meldenden Person und deren Ehepartner kontrollierten Limited Liability Company (LLC) gehalten werden.

Positive
  • None.
Negative
  • Director sold 32,437 shares in open-market transactions, reducing direct holdings reported on the form
  • Material portion of holdings held indirectly (53,375 shares) via an irrevocable family trust and an LLC, which may be less liquid from the issuer's perspective

Insights

TL;DR: Director executed multi-lot open-market sales totaling 32,437 NUS shares at ~ $12.10–$12.12 per share.

The sales are reported as routine open-market dispositions across multiple trades at slightly varying prices with weighted-average prices disclosed. Holdings remain both direct and indirect, indicating retained investment exposure via an irrevocable family trust and an LLC. The disclosure is standard for Section 16 insiders and provides full price range transparency for the trades.

TL;DR: Insider disclosed planned or executed disposals with ownership now split between direct and indirect holdings.

The form documents compliance with Section 16 reporting for a director-level insider. Indirect ownership through a family trust and an LLC is explicitly disclosed, which clarifies beneficial ownership structure. No derivative transactions or other compensatory issuances are reported, limiting governance complexity in this filing.

Daniel W. Campbell, amministratore di Nu Skin Enterprises (NUS), ha dichiarato vendite sul mercato aperto di azioni ordinarie di Classe A il 29/08/2025. Il documento riporta due operazioni di cessione: 9.046 azioni vendute a un prezzo medio ponderato di $12,12 e 23.391 azioni vendute a un prezzo medio ponderato di $12,10, per un totale di 32.437 azioni cedute. Dopo le operazioni il rapporto indica 39.216 azioni detenute direttamente e 53.375 azioni detenute indirettamente, incluse azioni in un trust familiare irrevocabile e in una società a responsabilità limitata controllata dalla persona segnalante e dalla sua coniuge.

Daniel W. Campbell, director de Nu Skin Enterprises (NUS), declaró ventas en mercado abierto de acciones ordinarias Clase A el 29/08/2025. La presentación muestra dos transacciones de disposición: 9.046 acciones vendidas a un precio promedio ponderado de $12,12 y 23.391 acciones vendidas a un precio promedio ponderado de $12,10, para un total de 32.437 acciones enajenadas. Tras las operaciones el informe muestra 39.216 acciones en posesión directa y 53.375 acciones en posesión indirecta, incluidas acciones mantenidas en un fideicomiso familiar irrevocable y en una sociedad de responsabilidad limitada controlada por la persona informante y su cónyuge.

Daniel W. Campbell은 Nu Skin Enterprises (NUS)의 이사로서 2025-08-29에 클래스 A 보통주에 대한 공개 시장 매도를 보고했습니다. 제출 문서에는 두 건의 처분 거래가 표시되어 있으며, 가중평균 가격 $12.12에 9,046주를 매도하고 가중평균 가격 $12.10에 23,391주를 매도하여 총 32,437주를 처분한 것으로 나옵니다. 거래 후 보고서에는 직접 보유 주식 39,216주와 간접 보유 주식 53,375주가 기재되어 있으며, 여기에는 취소 불가능한 가족 신탁과 보고자 및 배우자가 통제하는 유한책임회사(LLC)가 보유한 주식이 포함됩니다.

Daniel W. Campbell, administrateur de Nu Skin Enterprises (NUS), a déclaré des ventes sur le marché ouvert d'actions ordinaires de classe A le 29/08/2025. le dossier indique deux opérations de cession : 9 046 actions vendues à un prix moyen pondéré de 12,12 $ et 23 391 actions vendues à un prix moyen pondéré de 12,10 $, pour un total de 32 437 actions cédées. Après ces opérations, le rapport fait état de 39 216 actions détenues directement et de 53 375 actions détenues indirectement, y compris des actions détenues par un trust familial irrévocable et par une société à responsabilité limitée contrôlée par la personne déclarante et son conjoint.

Daniel W. Campbell, Direktor von Nu Skin Enterprises (NUS), meldete am 29.08.2025 Offenmarktverkäufe von Class-A-Stammaktien. Die Einreichung weist zwei Veräußerungstransaktionen aus: 9.046 Aktien verkauft zu einem gewichteten Durchschnittspreis von $12,12 und 23.391 Aktien verkauft zu einem gewichteten Durchschnittspreis von $12,10, insgesamt also 32.437 veräußerte Aktien. Nach den Transaktionen zeigt der Bericht 39.216 direkt gehaltene Aktien und 53.375 indirekt gehaltene Aktien, einschließlich Aktien, die in einem unwiderruflichen Familientrust und in einer von der meldenden Person und deren Ehepartner kontrollierten Limited Liability Company (LLC) gehalten werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CAMPBELL DANIEL W

(Last) (First) (Middle)
C/O NU SKIN ENTERPRISES, INC.
75 W CENTER STREET

(Street)
PROVO UT 84601

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/29/2025 S 9,046 D $12.12(1) 39,216 D
Class A Common Stock 08/29/2025 S 23,391 D $12.1(2) 53,375 I By an irrevocable family trust
Class A Common Stock 10,010 I By a limited liability company(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.10 to $12.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
3. Limited liability company owned and controlled by the Reporting Person and his spouse.
/s/ Gregory Belliston as Attorney-in-Fact for Daniel Campbell 08/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did the Form 4 for NUS disclose?

The Form 4 reports that director Daniel W. Campbell sold a total of 32,437 Class A shares in open-market transactions on 08/29/2025 at weighted-average prices of $12.12 and $12.10.

How many NUS shares does Daniel W. Campbell own after these transactions?

The filing shows 39,216 shares held directly and 53,375 shares held indirectly following the reported transactions.

What forms of indirect ownership are disclosed in the filing?

Indirect ownership is disclosed as shares held by an irrevocable family trust and by a limited liability company owned and controlled by the reporting person and his spouse.

Were any derivative securities reported in this Form 4 for NUS?

No derivative securities were reported; Table II is empty and the form only documents non-derivative common stock dispositions.

Does the filing disclose the exact per-trade prices for the sales?

The filing provides weighted-average prices and price ranges: sales ranged from $12.10 to $12.12, and the reporting person offers to provide full breakdowns on request.
Nu Skin Enter

NYSE:NUS

NUS Rankings

NUS Latest News

NUS Latest SEC Filings

NUS Stock Data

603.38M
47.11M
2.23%
74.85%
3.75%
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
PROVO